Multiple inflammatory cytokine-productive ThyL-6 cell line established from a patient with thymic carcinoma

Cancer Science

Volumn 99, Issue 9, 2008, Pages 1778-1784

  Inai, Kunihiro ^a   Takagi, Kazutaka ^a   Takimoto, Nobuo ^a   Okada, Hiromi ^a   Imamura, Yoshiaki ^a   Ueda, Takanori ^a   Naiki, Hironobu ^a   Noriki, Sakon ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CYTOKERATIN; CYTOKINE ANTIBODY; EPITHELIAL MEMBRANE ANTIGEN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; INTERMEDIATE FILAMENT PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULOTROPIN; VIMENTIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; CANCER CELL CULTURE; CANCER INHIBITION; CASE REPORT; CELL TRANSPLANTATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; EXPERIMENTAL MOUSE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; KARYOTYPE; LEUKOCYTOSIS; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTOSIS; THYMUS CANCER; THYMUS CARCINOMA; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MICE; MIDDLE AGED; THYMOMA;

EID: 50149095062     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00897.x     Document Type: Article

References (46)

1. Detterbeck FC, Egan TM. Thoracoscopy using a substernal handport for palpation. Ann Thorac Surg 2004; 78: 1031-6.
2. Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest 2005; 128: 2893-909.
3. Travis W, Brambilla E, Muller-Hermelink H, Harris C. Pathology and Genetics of Tumours of the Lung. Thymus and Heart Lyon: IARC Press, 2005.
4. Fernandez E, Vicente A, Zapata A et al. Establishment and characterization of cloned human thymic epithelial cell lines. Analysis of adhesion molecule expression and cytokine production. Blood 1994; 83: 3245-54.
5. Haynes BF, Denning SM, Le PT, Singer KH. Human intrathymic T cell differentiation. Semin Immunol 1990; 2: 67-77.
6. Ikeda T, Kawakami K, Fujita J, Bandoh S, Yamadori I, Takahara J. Thymic carcinoma associated with a high serum level of interleukin 6 diagnosed through the evaluation for asymptomatic elevation of acute-phase reactants. Intern Med 1998; 37: 414-16.
7. Matsumura N, Shiiki H, Saito N et al. Interleukin-6-producing thymic squamous cell carcinoma associated with Castleman's disease and nephrotic syndrome. Intern Med 2002; 41: 871-4.
8. Lee CK, Kim JK, Kim K, Han SS. A mouse thymic stromal cell line producing macrophage-colony stimulating factor and interleukin-6. Arch Pharm Res 2000; 23: 252-6.
9. Ichida K, Hosoyamada M, Hisatome I et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004; 15: 164-73.
10. Kuzume T, Kubonishi I, Takeuchi S et al. Establishment and characterization of a thymic carcinoma cell line (Ty-82) carrying t (15;19)(q15;p13) chromosome abnormality. Int J Cancer 1992; 50: 259-64.
11. Inai K, Iwasaki H, Noriki S et al. Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies. Int J Hematol 2007; 86: 225-32.
12. Jin Y, Sun A, Noriki S, Imamura Y, Fukuda M. Detection of cancer clones in human colorectal adenoma as revealed by increased DNA instability and other bio-markers. Eur J Histochem 2007; 51: 1-10.
13. Shimizu S, Yoshioka R, Hirose Y, Sugai S, Tachibana J, Konda S. Establishment of two interleukin 6 (B cell stimulatory factor 2/ interferon beta 2) -dependent human bone marrow-derived myeloma cell lines. J Exp Med 1989; 169: 339-44.
14. Ostapkowicz A, Inai K, Smith L, Kreda S, Spychala J. Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor. Mol Cancer Ther 2006; 5: 238-45.
15. Inai K, Tsutani H, Yamauchi T, Huberman E, Nakamura T, Ueda T. Differentiation induction in non-lymphocytic leukemia cells upon treatment with mizoribine. Int J Hematol 1997; 66: 335-44.
16. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 1992; 127: 25-50.
17. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci 2006; 97: 439-47.
18. Tsutani H, Yoshio N, Ueda T. Interleukin 6 reduces serum urate concentrations. J Rheumatol 2000; 27: 554.
19. Urano W, Yamanaka H, Tsutani H et al. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol 2002; 29: 1950-3.
20. Sun TT, Bonitz P, Burns WH. Cell culture of mammalian thymic epithelial cells: Growth, structural, and antigenic properties. Cell Immunol 1984; 83: 1-13.
21. Baba M, Hasegawa H, Nakayabu M et al. Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: The presence of autocrine growth control by G-CSF. Am J Hematol 1995; 49: 207-15.
22. Asahi Y, Kubonishi I, Imamura J et al. Establishment of a clonal cell line producing granulocyte colony-stimulating factor and parathyroid hormone-related protein from a lung cancer patient with leukocytosis and hypercalcemia. Jpn J Cancer Res 1996; 87: 451-8.
23. Kondo K, Okada T, Matsui T et al. Establishment and characterization of a human B cell line from the lung tissue of a patient with scleroderma; extraordinary high level of IL-6 secretion by stimulated fibroblasts. Cytokine 2001; 13: 220-6.
24. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 2005; 8: 63-71.
25. Inoue Y, Tsushima H, Ando K et al. Chemokine expression in human erythroid leukemia cell line AS-E2: Macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines. Exp Hematol 2006; 34: 19-26.
26. Sekido Y, Sato M, Usami N et al. Establishment of a large cell lung cancer cell line (Y-ML-1B) producing granulocyte colony-stimulating factor. Cancer Genet Cytogenet 2002; 137: 33-42.
27. Tachibana M, Miyakawa A, Nakashima J et al. Autocrine growth promotion by multiple hematopoietic growth factors in the established renal cell carcinoma line KU-19-20. Cell Tissue Res 2000; 301: 353-67.
28. Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999; 60: 508-14.
29. Hishima T, Fukayama M, Fujisawa M et al. CD5 expression in thymic carcinoma. Am J Pathol 1994; 145: 268-75.
30. Nakagawa K, Matsuno Y, Kunitoh H, Maeshima A, Asamura H, Tsuchiya R. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest 2005; 128: 140-4.
31. Sait SN, Brooks JJ, Ashraf M, Zhang PJ. A novel t(1;8)(p13;p11) in a thymic carcinoma with unusual giant cell features and renal metastasis. Cancer Genet Cytogenet 2001; 124: 140-3.
32. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol 2002; 15: 6-10.
33. Kaufmann O, Fietze E, Mengs J, Dietel M. Value of p63 and cytokeratin 5/ 6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001; 116: 823-30.
34. Zettl A, Strobel P, Wagner K et al. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 2000; 157: 257-66.
35. Knuutila S, Bjorkqvist AM, Autio K et al. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 1107-23.
36. McManus AP, Min T, Swansbury GJ, Gusterson BA, Pinkerton CR, Shipley JM. Der(16)t(1;16)(q21;q13) as a secondary change in alveolar rhabdomyosarcoma. A case report and review of the literature. Cancer Genet Cytogenet 1996; 87: 179-81.
37. Mugneret F, Sidaner I, Favre B et al. Der(16)t(1;16)(q10;p10) in multiple myeloma: A new non-random abnormality that is frequently associated with Burkitt's-type translocations. Leukemia 1995; 9: 277-81.
38. Mugneret F, Dastugue N, Favre B et al. Der(16)t(1;16)(q11;q11) in myelodysplastic syndromes: A new non-random abnormality characterized by cytogenic and fluorescence in situ hybridization studies. Br J Haematol 1995; 90: 119-24.
39. Sheng WW, Soukup S, Bove K, Gotwals B, Lampkin B. Chromosome analysis of 31 Wilms' tumors. Cancer Res 1990; 50: 2786-93.
40. Birch NC, Antonescu CR, Nelson M et al. Inconspicuous insertion 22;12 in myxoid/round cell liposarcoma accompanied by the secondary structural abnormality der(16)t(1;16). J Mol Diagn 2003; 5: 191-4.
41. Tsuda H, Takarabe T, Fukutomi T, Hirohashi S. Preferential occurrence of breast carcinomas with loss of chromosome 16q and der(16)t(1;16)/der (1;16) in middle-aged patients with hyperplasia of mammary glands. Jpn J Cancer Res 2000; 91: 692-9.
42. Mugneret F, Lizard S, Aurias A, Turc-Carel C. Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16). Cancer Genet Cytogenet 1988; 32: 239-45.
43. Velagaleti GV, Miettinen M, Gatalica Z. Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation (malignant triton tumor) with balanced t(7;9)(q11.2;p24) and unbalanced translocation der(16)t(1;16) (q23;q13). Cancer Genet Cytogenet 2004; 149: 23-7.
44. Sonobe H, Ohtsuki Y, Nakayama H, Asaba K, Nishiya K, Shimizu K. A thymic squamous cell carcinoma with complex chromosome abnormalities. Cancer Genet Cytogenet 1998; 103: 83-5.
45. Eimoto T, Kitaoka M, Ogawa H et al. Thymic sarcomatoid carcinoma with skeletal muscle differentiation: Report of two cases, one with cytogenetic analysis. Histopathology 2002; 40: 46-57.
46. Rodriguez C, Grosgeorge J, Nguyen VC, Gaudray P, Theillet C. Human gp130 transducer chain gene (IL6ST) is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11. Cytogenet Cell Genet 1995; 70: 64-7.